OpenApp take home the Excellence in CSR by an SME Award in Corporate Social Responsibility Award 2018
OpenApp has been awarded the Excellence in CSR by an SME in the Chambers Ireland Corporate Social Responsibility (CSR) Awards 2018.
OpenApp won for their project Rare100. Rare diseases affect an estimated 300 million people around the world and 30 million in Europe alone. Despite this, there is no cure for the majority of rare diseases and many go undiagnosed. Rare100 provides a free web-enabled patient registry for patient organisations supporting an ultra-rare condition. This enables organisations to gather data which will improve the lives of people suffering with rare diseases.
OpenApp’s CSR programme demonstrated company-wide engagement and impressed the judging panel by performing consistently well across all aspects of CSR. OpenApp was presented with a specially commissioned trophy designed by Waterford Crystal.
Speaking at the Awards ceremony was Sara Viegas, Product Manager, OpenApp
“ We are delighted to win this award. Rare100, is a feature rich, free web-enabled patient registry for patient organisations with a population of less than 100 patients.
We have a number of patient organisations who are benefiting from Rare100 including ultra rare diseases such as Tay Sachs and MSD. The CATS foundation which is the patient organisation behind Tay Sachs in the UK is close to getting a clinical trial underway, because of their patient registry. This is great news for a disease that has no known cure or treatment. We are humbled to receive this award on behalf of the company and the organisations we work with.”
Ian Talbot, Chief Executive of Chambers Ireland said at the Awards ceremony,
“Ireland today is a wellspring of vital and inventive CSR practices across the business spectrum and the annual CSR Awards are the perfect opportunity to celebrate and pay tribute to the most exciting projects happening today. Over the past fifteen years of the awards, the bar continues to be raised in terms of the level of ingenuity behind each applicant’s projects as well as the depth of engagement with sustainable and socially responsible goals.
Congratulations to OpenApp and the winners of the fourteen excellence in CSR award categories, whom we recognise for their achievements in best practice CSR.”
Founded in 2002, we are a healthcare IT company that has grown to nearly 50 employees, are blazing a trail to support the rare disease communities. Learn more about our work here.
Latest News
Real-World Data Collection Enables Evaluating the Safety and Effectiveness of Treatments for Spinal Muscular Atrophy
This exciting initiative combines collecting real-world patient data by neurologists, clinicians and patients to enable clinical research and engagement of spinal muscular atrophy patients receiving treatment.
SMArtCARE is a multi-year joint initiative of neurologists, paediatricians, and patients with spinal muscular atrophy (SMA). Spinal muscular atrophy refers to a group of rare genetic diseases resulting in muscle wastage and weakness. Symptom onset can be seen in both children and adults but the most severe form typically presents in children under 18 months old. Until recent treatments survival past childhood was unusual.
Read More
Childrens Tumor Foundation Innovative Patient Reported Patient Registry Platform
The NF registry is a one of a kind project, where the OpenApp team worked in collaboration with CTF to develop and support a platform that meets their requirements, as a secure and effective tool to empower NF patients and their caregivers. A dedicated registry is the most efficient way to raise awareness/advocate for NF, expand the NF community, and connect to help end NF.
Read More
Why You Need A Software Maintenance Management Plan
Combining the development efforts and the ongoing maintenance of your software is key to ensuring that you have a robust and constantly improving and evolving solution.
Having a software maintenance plan is just as important as the initial development. Professionally managed maintenance allows for the continual improvement and adaptation to changing business needs and technological advancements.
Read More
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights. Learn more at www.iqvia.com.
Copyright © 2024 | Privacy Policy
OpenApplications Consulting Ltd. Registered in Ireland No. 355595